Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-030008

Chief Scientific Officer acquired 11,588 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sethuraman Natarajan · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 1 in the form +11,588 156,350 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +69,525 69,525 D
Loading xslF345X03/tm228284-4_4seq1.xml…